New metallo β-lactamase NDM-1
2010

Understanding NDM-1 and Antimicrobial Resistance

Sample size: 3521 Editorial Evidence: moderate

Author Information

Author(s): Raghunath D.

Primary Institution: Sir Dorabji Tata Centre for Research in Tropical Diseases, Innovation Centre Indian Institute of Science

Conclusion

NDM-1 confers resistance to almost all β-lactam antibiotics, making infections difficult to treat.

Supporting Evidence

  • NDM-1 is a novel metallo β-lactamase that confers resistance to almost all β-lactam antibiotics.
  • Isolates with NDM-1 have been found in multiple countries, indicating widespread distribution.
  • Patients traveling to India for surgery may be at risk of infections from NDM-1 carrying bacteria.

Takeaway

Some bacteria have become super strong and can resist almost all medicines, making it hard to treat infections.

Methodology

The study included epidemiological data from two sites in India, analyzing isolates for NDM-1 prevalence.

Potential Biases

The designation of NDM-1 may be influenced by non-scientific agendas regarding medical tourism.

Limitations

The epidemiology of NDM-1 has not been systematically studied, and the presence of the organism does not guarantee infection.

Participant Demographics

Isolates were from patients with community-acquired infections, including urinary tract infections and pneumonia.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication